In today’s briefing:
- BMRI IJ Initiation: Growth at Reasonable Price!
![](http://www.smartkarma.com/assets/plugins/a3-lazy-load/assets/images/lazy_placeholder.gif)
BMRI IJ Initiation: Growth at Reasonable Price!
- BMRI is more profitable than BBNI, less cyclical than BBRI and less expensive than BBCA. This combination makes it an attractive play on the Indonesia credit growth story.
- BMRI’s FY23 results are a strong beat with industry-leading loan growth and strong ROE; BMRI also has the potential to aggressively grow its retail portfolio which still is likely under-appreciated
- BMRI still trades at a discount to BBRI and has the potential to re-rate by another 20% in the near term, apart from the compounding driven by strong loan growth.